loader
Please Wait
Applying Filters...

Looking for (17beta)-17-Hydroxyandrost-4-en-3-one? Find Disintegrants & Superdisintegrants used in (17beta)-17-Hydroxyandrost-4-en-3-one to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 436Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Jai Radhe Sales

02 7Gangwal Healthcare

03 8Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

04 2DFE Pharma

05 4Gangwal Chemicals

06 1Ingredion Pharma Solutions

07 2Kima Chemical

08 1Novo Excipients

09 1Pharmatrans-Sanaq

10 5Pluviaendo

11 1Prachin Chemical

12 1Qianhao Chemical (Hebei) Co., Ltd

13 14Roquette

14 2Shanghai Shenmei Pharmaceutical Technology Co., Ltd

15 2Sigachi Industries

16 3Ulanqab Kema New Material

17 4Vasa Pharmachem

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : SALLYSO™

Applications : Sallyso (Croscarmellose Sodium) is used as a disintegrating agent in tablets, capsules & granules for enhancing API dissolution and bioavailability.

Pharmacopoeia Ref : IP/BP/EP/USP-NF

Technical Specs : Sallyso 0.5 to 3.0%

Grade : Oral

arrow

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

05

arrow
2024 ACI Convention
Not Confirmed

07

arrow
2024 ACI Convention
Not Confirmed

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

12

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

13

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

14

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

15

arrow
2024 ACI Convention
Not Confirmed

16

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

18

arrow
2024 ACI Convention
Not Confirmed

23

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

25

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : F-MELT TYPE M

Applications : F-Melt Type M is used in various dosage forms like orally disintegrating tablets (ODTs), sachets, dispersible tablets, chewable tablets and sublingual formulations.

Pharmacopoeia Ref : Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP and EP.

Technical Specs : Not Available

Grade : Oral

arrow
blank

26

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : F-MELT TYPE C

Applications : F-Melt Type C is a pharmaceutical excipient used in oral dosage forms like orally disintegrating tablets, sachets, dispersible tablets, chewable tablets and sublingual tablets.

Pharmacopoeia Ref : Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, EP. US DMF Type IV filed.

Technical Specs : Not Available

Grade : Oral

arrow
blank

28

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : MAIZE STARCH B

Applications : Used as disintegrants, fillers and binders (once cooked) in nutraceutical and pharmaceutical dosage forms.

Pharmacopoeia Ref : EP/USP/JP

Technical Specs : Not Available

Grade : Not Available

arrow
blank

29

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : POWDERED NF CORN STARCH

Applications : Used as disintegrants, fillers and binders (once cooked) in nutraceutical and pharmaceutical dosage forms.

Pharmacopoeia Ref : NF

Technical Specs : Not Available

Grade : Not Available

arrow
blank